| Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B MF Yuen, Y Tanaka, DYT Fong, J Fung, DKH Wong, JCH Yuen, DYK But, ... Journal of hepatology 50 (1), 80-88, 2009 | 671 | 2009 |
| Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications MF Yuen, HJ Yuan, DKH Wong, JCH Yuen, WM Wong, AOO Chan, ... Gut 54 (11), 1610-1614, 2005 | 521 | 2005 |
| HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma MF Yuen, DKH Wong, J Fung, P Ip, D But, I Hung, K Lau, JCH Yuen, ... Gastroenterology 135 (4), 1192-1199, 2008 | 453 | 2008 |
| HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects MF Yuen, DKH Wong, E Sablon, E Tse, IOL Ng, HJ Yuan, CW Siu, ... Hepatology 39 (6), 1694-1701, 2004 | 372 | 2004 |
| Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study WK Seto, TSY Chan, YY Hwang, DKH Wong, J Fung, KSH Liu, H Gill, ... Journal of Clinical Oncology 32 (33), 3736-3743, 2014 | 351 | 2014 |
| Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease MF Yuen, WK Seto, DHF Chow, K Tsui, DKH Wong, VWS Ngai, ... Antiviral therapy 12 (8), 1295-1304, 2007 | 332 | 2007 |
| Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients DKH Wong, MF Yuen, HJ Yuan, SSM Sum, CK Hui, J Hall, CL Lai Hepatology 40 (3), 727-737, 2004 | 251 | 2004 |
| hepatitis B core‐related antigen (HB crAg): an emerging marker for chronic hepatitis B virus infection LY Mak, DKH Wong, KS Cheung, WK Seto, CL Lai, MF Yuen Alimentary pharmacology & therapeutics 47 (1), 43-54, 2018 | 225 | 2018 |
| Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma MF Yuen, E Sablon, HJ Yuan, DKH Wong, CK Hui, BCY Wong, ... Hepatology 37 (3), 562-567, 2003 | 220 | 2003 |
| Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection DKH Wong, Y Tanaka, CL Lai, M Mizokami, J Fung, MF Yuen Journal of clinical microbiology 45 (12), 3942-3947, 2007 | 216 | 2007 |
| Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels MF Yuen, Y Tanaka, N Shinkai, RT Poon, DYK But, DYT Fong, J Fung, ... Gut 57 (1), 98-102, 2008 | 213 | 2008 |
| Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5‐year ideal response MF Yuen, DYT Fong, DKH Wong, JCH Yuen, J Fung, CL Lai Hepatology 46 (6), 1695-1703, 2007 | 211 | 2007 |
| Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial DJ Gladstone, P Dorian, M Spring, V Panzov, M Mamdani, JS Healey, ... Stroke 46 (4), 936-941, 2015 | 208 | 2015 |
| Salmonella enterica Serovar Typhi Uses Type IVB Pili To Enter Human Intestinal Epithelial Cells XL Zhang, ISM Tsui, CMC Yip, AWY Fung, DKH Wong, X Dai, Y Yang, ... Infection and immunity 68 (6), 3067-3073, 2000 | 207 | 2000 |
| Three years of continuous entecavir therapy in treatment-naive chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety MF Yuen, WK Seto, J Fung, DKH Wong, JCH Yuen, CL Lai Official journal of the American College of Gastroenterology| ACG 106 (7 …, 2011 | 203 | 2011 |
| A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy MF Yuen, HJ Yuan, CK Hui, DKH Wong, WM Wong, AOO Chan, ... Gut 52 (3), 416-419, 2003 | 201 | 2003 |
| Hepatitis B virus core‐related antigen as a surrogate marker for covalently closed circular DNA DKH Wong, WK Seto, KS Cheung, CK Chong, FY Huang, J Fung, CL Lai, ... Liver International 37 (7), 995-1001, 2017 | 195 | 2017 |
| Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma DKH Wong, FY Huang, CL Lai, RTP Poon, WK Seto, J Fung, IFN Hung, ... Hepatology 54 (3), 829-836, 2011 | 193 | 2011 |
| Reduction of covalently closed circular DNA with long-term nucleos (t) ide analogue treatment in chronic hepatitis B CL Lai, D Wong, P Ip, M Kopaniszen, WK Seto, J Fung, FY Huang, B Lee, ... Journal of hepatology 66 (2), 275-281, 2017 | 189 | 2017 |
| Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B WK Seto, DKH Wong, J Fung, FY Huang, KSH Liu, CL Lai, MF Yuen Clinical Microbiology and Infection 20 (11), 1173-1180, 2014 | 165 | 2014 |
